Henry Ford Allegiance Health is a 475-bed health system in Jackson in the U.S. state of Michigan. Henry Ford Allegiance Health has more than 400 physicians and 3,700 staff members. The health system offers specialized services including a new cancer center and a heart center with a 20-bed cardiac universal bed unit.

During the past decade, Allegiance Health conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 166 clinical trials were completed, i.e. on average, 139.5% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 78 clinical trials were completed. i.e. 269% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allegiance Health" #1 sponsor was "National Cancer Institute (NCI)" with 144 trials, followed by "SWOG Cancer Research Network" with 41 trials sponsored, "Alliance for Clinical Trials in Oncology" with 37 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Gynecologic Oncology Group" with 15 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allegiance Health" #1 collaborator was "National Cancer Institute (NCI)" with 129 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Allegiance Health" are "Breast Cancer" (13 trials), "Recurrent Breast Carcinoma" (13 trials), "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (10 trials). Many other conditions were trialed in "Allegiance Health" in a lesser frequency.

Most popular intervention types in "Allegiance Health" are "Drug" (242 trials), "Other" (165 trials), "Biological" (104 trials), "Procedure" (57 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (99 trials), "Quality-of-Life Assessment" (55 trials), "Paclitaxel" (34 trials), "Cisplatin" (30 trials) and "Carboplatin" (28 trials). Other intervention names were less common.

The vast majority of trials in "Allegiance Health" are 225 trials for "All" genders, 57 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Allegiance Health". undefined are not yet recruiting, 28 are recruiting, 114 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Allegiance Health, 4 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Allegiance Health, 14 "Phase 1" clinical trials were conducted, 152 "Phase 2" clinical trials and 134 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".

Allegiance Health has several departments that took part in Clinical trials: "Center for Hematology/Oncology of S. Michigan" - 4 trials